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The infusion of 7,12 dimethylbenz(a)anthracene 
(DMBA) dissolved in DMSO:glycofurol into adult guinea 
pigs rendered most recipients unresponsive to the induc-
tion of contact sensitization with DMBA, either by injec-
tion in adjuvant or topical application. The results were 
similar when guinea pigs infused with DMBA dissolved 
in Upjohn fat emulsion, were challenged with DMBA in 
adjuvant, but studies attempting topical sensitization to 
demonstrate unresponsiveness were inconclusive. Mam-
mary tumors appeared after a latent period of 8 to 11 mo 
in 4 guinea pigs infused with DMBA in fat emulsion in 
which topical sensitization with DMBA was attempted. 
Immunologic unresponsiveness to contact sensitization with 
simple chemicals may be produced by either feeding or infusion 
of the compound [1]. The recognition that certain chemical 
carcinogens also have contact sensitizing properties, prompted 
experiments demonstrating that it is possible to induce unre-
sponsiveness to contact sensitization with carcinogens by prior 
feeding of the chemical [2]. The methods employed and results 
are similar to those observed in producing tolerance to simple 
chemical haptens, such as picryl chloride. 
The present investigation was undertaken to determine if 
tolerance to the contact sensitizing property of a carcinogen, 
dimethylbenz(a)anthracene (DMBA) , could also be accom-
plished by administering the carcinogen intravenously, as can 
be done with simple chemical haptens. Although the best 
method of demonstrating unresponsiveness is to attempt sen-
sit ization by injecting the carcinogen in adjuvant, parallel ex-
periments employing topical application of the caTcinogen as 
the sensitizing challenge were performed. This was done be-
cause future experiments envisioned the use oftolerized animals 
to determine if altered immunity to a chemical caTcinogen 
affects tumor induction with the same compound. The use of 
adjuvant in such a study would be proscribed because adjuvant 
is known to influence tumorigenesis. 
The experiments reported indicate that it is possible to induce 
tolerance to contact sensitization with the carcinogen, DMBA, 
by prior infusion of the chemical. In the course of these studies 
it was also found that when sensitization was attempted utilizing 
topical application of the carcinogen, rather than footpad injec-
tion with complete Freunds adjuvant; some of the animals 
infused with DMBA in fat emulsion developed mammary tu-
mors eight to nine months later. 
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MATERIALS AND METHODS 
Animals 
Random bred, ma le and female, Hartley strain guinea pigs weighing 
300- 400 gm were obtained from Beaumanor FaJ"ms, Cleveland, Ohio. 
Chemica.ls 
DMBA (97% puJ"e) was obtained from the S igma Chemical Company, 
St. Louis, Missomi. The glycofmol was generously supplied by Dr. 
W.E. Scott of Hoffman-La Roche, Nutley, New J ersey. The DMSO 
was obtained from the F isher Scientific Company, Pi ttsburgh, Penn-
sylvania. Upjohn in travenous fat emulsion without dextrose (Lipomil) 
with and without 0.5% w/ v DMBA (5 mg/ ml) was supplied by Dr. Paul 
E. Schurr of the Upjohn Company, Kalamazoo, Michigan. 
So lvents and Techniques Used for Intravenous InJection. 
DMBA was clissolved in a mixture of glycofurol and dimethylsulf-
oxide (DMSO) 1:1. The guinea pigs were immobilized and an incision 
made on the inner aspect of the thigh to expose the subcutaneous vein. 
A sterile , 25 gauge needle was inserted into the vein for each infusion 
and the appropriate volume of solvent conta ining the desired dose of 
DMBA in either glycofurol:DMSO or Lipomol was slowly administered. 
If any evidence of infrl tration or extravasation during the injection 
appeared, the animal was discarded. After the needle was removed, 
pressure was applied for 30 to 60 seconds. When the animal resumed 
its normal stance, the skin margins were approximated and the wounds 
generally healed without difficulty. 
Contact Sensitization 
Injection of DMBA in adjuvant: The DMBA was dissolved in corn 
oil and mixed 1:3 with complete Freunds adjuvan t H:11RA (Difco 
Laboratories, Detroit, Michigan) to give a final concentration of 75 
J..Lgms./0.1 ml of emulsion. One-tenth ml was injected into each footpad. 
Epicutaneous application: Topical sensitization was attempted by 
2 epicutaneous applications of 50 J..LL. of 10% DMBA in safflower oil to 
the clipped skin of the back, applied two days apart (total dose 10,000 
/~gms. ) 
Detection of contact reactivity: Fifty J..Ll. of a 1, 0.5, and 0.1% (w/ v) 
solu tion of DMBA in acetone olive oil 4:1 was applied with a micro-
syringe to the clipped flank skin covering an area of about 7 cm. 2• The 
tests were read at 24 hT as follows: 4+ confluent, bright pink, erythema 
with clistinct thickening, elevation and necrosis; 3+ pink, cont1uent, 
macular erythema with a slightly thickened elevated edge; 2+ light 
pink, confluent, macular erythema; 1 + fa in t pink, macular erythema; 
Tr (trace) faint, pink spots; FtTr very fain t pink spots. 
A 1+ reaction at both the 1% and 0.5% sites was required to consider 
an anima l sensitized. This was because DMBA was found to have 
variable primary irritant properties from animal to animal at the 1% 
concentration. Trace and fa in t trace responses are no t uncommon in 
previously unexposed animals and occasionally a 1% reaction may occur 
even with lower concentrations. Thus, a negative response at the 1% 
site clearly indicates an absence of contact reactivity. 
Detection of tuberculin hypersensitivity : Guinea pigs immunized 
with carcinogen in complete Freunds adjuvant were tested for concom-
itant tuberculin sensit ivity by in tradermal injection of 0.1 ml in te rme-
diate strength purified protein derivative (PPD) , Merck, Sharp and 
Dome, Westpoint, Pennsylvania. An erythematous papule 5 mm or 
larger, was considered a positive reaction. 
Detection of immunologic unresponsiveness to contaCt sensitization.: 
Active sensitization was attempted by the injection of 75 J..Lgms. of 
DMBA in complete Freunds adjuvant (H"1RA, Difco Laboratories) 
in to each footpad for a total of 300 J..Lgm. 
Topical sensitization was attempted with two applications of 50 J.LL. 
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of 10% DMBA in safflower oil to the clipped skin of the back, applied 
2 days apart (total dose 10,000 11gm) . 
These procedures regularly induce contact reactivity to DMBA in 
most recipients. Failure to develop contact dermat itis was considered 
to indicate the presence of immunologic umesponsiveness to contact 
sensitization. • 
Experimental Sequence: Day 1. Carcinogen infused; Day 14-initial 
contact tests applied; Day IS-initial contact tests read; Day 21-active 
sensitization with footpad injection of DMBA in adjuvant or first of 
topical applications of DMBA; Day 23-second topical app lication; 
Day .35-final contact tests applied. Day +.36-contact tests read. 
RESULTS 
Experiments in Which DMBA Infusion Was Followed by 
Attempted Sensitization with DMBA in Complete Freunds 
Adjuvant 
The results of infusing guinea pigs with DMBA in glycofurol: 
DMSO 1:1 or Upjohn fat emulsion (Lipomil) are shown in 
Table I. Initial contact tests 2 weeks following the infusion 
:revealed that although almost all the recipients in either exper-
imental or control groups did not respond, occasional animals 
in each group did have positive 1 + contact reactions at the 1% 
and 0.5% test sites, but not at the 0.1% sites. The responses in 
these animals undoubtedly represent primary irritant reactions 
in the control groups and probably in the experimental animals 
as well. However, one of the initially positive experimental 
animals died prior to attempted sensitization and the other was 
negative when retested after immunization with DMBA in 
adjuvant. Thus, the possibility of transient hypersensitivity in 
the experimental animals cannot be absolutely excluded. 
With only 2 exceptions, attempted sensitization with 300 tJ.gm 
of DMBA in complete Freunds adjuvant, one week after the 
initial contact tests, failed to induce contact reactivity in the 
DMBA infused animals. N either of these 2 DMBA infused, 
sensitized animals had reactions greater than 1 + at the 1% and 
0.5% test sites, and both were trace or negative at the 0.1% test 
sites. In contrast, all but a few of the controls developed contact 
:reactivity to DMBA and the intensity of the responses in the 
control groups was more pronounced. Most (10 of 16) had 
greater than 1 + reactions at the 1% contact test site, and a 
number (7 of 16) reacted at the 0.1% site as well. There were no 
significant differences in the intensity of the reactions between 
the controls infused with glycofuroi:DMSO, or those given 1 or 
4 ml. of Upjohn fat emulsion. Repeat contact tests several 
months later revealed similar results. 
All of the animals in both the experimental and control 
groups had positive reactions to intradermal PPD with the 
exception of one control with a borderline negative response, 
indicating that the infusion of DMBA in either solvent did not 
interfere with the animal's capacity to develop delayed reactiv-
ity. 
Experiments in Which DMBA Infusion Was Followed by 
Attempted Sensitization With Topical Application of the 
Carcinogen 
The effects of infusing DMBA in glycofurol:DMSO and Up-
john fat emulsion followed by attempted topical sensitization 
are shown in Table II. Contact test r esponses 2 weeks after the 
initial infusion were sin1ilar to those in the previous experiments 
in that most recipients were negative. However, 2 experimentaJ 
a nimaJs had positive reactions to the initial contact tests, but 
were negative when retested following attempted topical sen-
sitization. These positive tests probably represent primary ir-
ritant reactions, although transient hypersensitivity cannot be 
excluded. The positive response in a control animal is consistent 
with a primary irritant reaction. 
• Subsequent experiments have shown that a more effective method 
of topical sensitiza tion to DMBA is to apply 50 ,uL to 2 sites on the 
back of the neck, 3 t imes at 3-day in tervals for a tota l of 30,000 11gm. 
The topical sensitization procedure induced contact reactiv-
ity to DMBA in most (3 of 4) of the controls infused with 1 ml 
of DMSO:glycofurol solvent, but with one exception failed to 
sensitze the experimental animals infused with 5 or 30 mg of 
DMBA. However, the intensity of the responses among the 
controls was considerably less than the previous experimen ts 
utilizing immunization with DMBA in complete adjuvant. None 
had readings of greater than 1 + at either the 1% or 0.5% test 
sites. 
The results in animaJs infused with Upjohn fat emulsion are 
not conclusive. Although topical sensitization induced contact 
reactivi ty in most (5 of 6) of the control animaJs infused with 1 
ml. of the solvent alone, only half of those infused with 5 mg of 
DMBA in 1 ml of Upjohn fat emulsion had negative contact 
tests. In control animals infused with 4 ml of solvent, topicaJ 
sensitization induced contact reactivity in only half (3 of 6) and 
thus the failure to develop reactivity in animals infused with 20 
mg of DMBA in 4 ml of Lipomil is not meaningful 
These animals were observed for periods of up to 1 yr 
following the infusion of DMBA in fa t emulsion and 4 guinea 
pigs developed mammary tumors interpreted to be breast pap-
illary adenocarcinomas after a latent period of 8-11 mo. Two 
animals that had been sensitized by the topical application of 
DMBA developed tumors, as did 2 that had failed to respond. 
Evidence of metastasis was not noted. 
DISCUSSION 
The results of these experiments indicate that infusion of the 
carcinogen, DMBA, into adult guinea pigs suppresses the ca-
pacity to respond to i.nm1Unization with DMBA in complete 
Freunds adjuvant in a significant number of the recipients. 
However, when sensitization was attempted by topicaJ appli-
cation of the carcinogen, it was possible to demonstrate unre-
sponsiveness in animals infused with DMBA in glycofurol: 
DMSO, but not those infused with DMBA in Upjohn fat 
emulsion. This may be because topical DMBA is a weaker 
stimulus for inducing contact reactivity and/ or that the infusion 
of a large volume of fat emulsion may suppress the recipient's 
ability to develop contact reactivity after topical immunization 
(3]. 
The immunologic unresponsiveness is comparable to that 
observed following infusion of simple chemical sensitizers, such 
as picryl chloride. The phenomenon is specific and presumably 
long lasting. Although DMBA may have immunosuppressive 
properties, the infusion did not interfere with the animal's 
ability to develop delayed hypersensitivity to PPD when im-
munized with the carcinogen in complete Freunds adjuvant 
(4]. 
Possibly la1·ger or multiple infusions would result in greater 
or more uniform unresponsiveness to contact sensitization, but 
these studies aTe limited by the solubility of the car cinogen in 
the solvent, and the toxicity of both the carcinogen and solvent. 
Previous experiments with picryl chloride had shown that 
infusion of the hapten stimulated the formation of picryl specific 
ant ibody in many of the recipients, and that red cells from 
hapten infused animaJs had the capacity to sensit ize fresh 
animals when injected into their footpads with adjuvant [5,6). 
The present studies did not include testing for humoral anti-
body to carcinogen protein conjugates. However, preliminary 
experiments attempting to sensitive fr esh animaJs with washed 
erytlu·ocytes, obtained 3 and 24 hr following the DMBA infu-
sion were negative, except for sporadic animals with very weak 
Tesponses which could not be differentia ted from primary irri-
tant reactions. The inability to transfer sensitizing capacity 
with washed cells obtained from DMBA infused ani.maJs, is 
probably a function of the fact t hat DMBA is chemically 
considerably less reactive than picryl chloride. 
The appearance of mammary tumors in DMBA infused ad ult 
male and female guinea pigs is noteworthy because spontaneous 
tumors are extremely uncommon in this species [8,9]. The 
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TABLE I. Unresponsiveness to Contact Sensitization in DMBA Infused Guinea Pigs 
Result of initial infusion Hesult of attempted sensitization With 300 p.gm DMBA in footpads 
Solvent Dose and vol. infused Contact reaction to DMBA 14 days later Contact reaction to DMBA 14 Days PPD reaction later 
No. Animals Positive(' Negative No. Animals Positive" Negative Positive Negative 1% 0.5% 1% 0.5% 
Glycofurol 5 mg 6 0 6 6 0 6 6 0 
DMSO 1:1 (1 ml) 
30 mg 7 l'J,d 6 6 5 6 0 
(1 ml) 
Control 0 mg 7 0 7 7 5 2 7 0 
(l ml) 
Upjohn Fat 5 mg 7 1" 6 7 6 7 0 
Emulsion (1 ml) 
5 mg/ ml 
Control 0 mg 4 1 c 3 4 3 1 5 0 
(1 ml) 
30 mg 7 0 7 7 0 7 7 0 
(4 ml) 
Control 0 mg 6 1'' 5 5" 5 0 4 
(4 ml) 
" 1 +or better response at 1% and 0.5% contact test sites. 
1
' Probable primary irritancy, transient hypersensitivity cannot be excluded. 
' Probable primary irritancy. 
<I One died. 
TABLE II. Unresponsiveness to contact sensitization in DMBA infused guinea pigs 
Resul t of initial infusion Result of attempted topical sensitization 
Solvent Dose and vol. infused 
Contact reaction to DMBA 14 days later Contact reaction to DMBA 14 days later 





5 mg/ ml 
5 mg 5 
(1 ml) 
30 mg 5 
(l ml) 
Control 0 mg 4 
(1ml) 
5 mg 6 
(1 ml) 
Control 0 mg 6 
(I ml) 
20 mg 9 
(4 ml) 
Control 0 mg 6 
(4 m]) 








3 5 0 5 
5 5 4 
4 4 3 
6 6 3 3 
6 6 5 1 
9 9 3<1 6' 
5 6 3 3 
"Probable primary irritancy, transient hypersensitivity cannot be excluded. 
' Probable primary irritancy. 
<I One female, one male developed mammal'y tumors. 
' Two females developed mammary tumors. 
induction of these tumors in animals in which sensitization was 
attempted by the topical route is intriguing and will be the 
subject of a subsequent communication. 
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